US 10435473
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted A61KA61K39/39591A61K47/183
Quick answer
US patent 10435473 (Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K39/39591, A61K47/183, A61K9/0019, A61P